Engineering Immunomodulatory Scaffolds for Dental Pulp Regeneration

用于牙髓再生的免疫调节支架工程

基本信息

项目摘要

PROJECT SUMMARY This K01 award describes a 3-year training program to support Dr. Franca's transition to scientific independence. Dr. Franca is a dentist-scientist, and her long-term goal is to lead a research program to (i) develop immunomodulatory biomaterials for dental and craniofacial regeneration and (ii) to create tissue chips to understand and treat oral diseases. The scientific goal of this K01 is to develop an immunomodulatory scaffold for dental pulp regeneration. Despite undeniable progress to develop regenerative strategies for the dental pulp, necrotic teeth present challenging conditions for regeneration. Even after careful disinfection, a previously infected root canal's microenvironment has remnant lipopolysaccharide (LPS) that activates immune cells into a pro-inflammatory state incompatible with tissue regeneration. Recently, early events of the immune response were shown to highly influence tissue engineering strategies' success. Especially, macrophage responses to biomaterials have been identified as essential mediators of scaffold remodeling and promising targets for immune-mediated regenerative strategies. These cells can respond to external stimuli by changing their phenotype from pro-inflammatory to pro-regenerative, with many intermediate states, in a process known as M1/M2 polarization. These two states are highly plastic, function synergistically, and can be modulated by the scaffold's properties. When a scaffold for dental pulp regeneration is placed in contact with LPS-contaminated dentin, it can be expected that M1 activation will persist without providing the pro-regenerative environment necessary for tissue formation. Small antibodies or nanobodies have been used to neutralize LPS in Gram-negative infections and target pathogens in scarcely accessible tissue microenvironments. Unfortunately, this therapeutic tool has not been used for dental regeneration purposes. Our overarching hypothesis is that an immunomodulatory scaffold that neutralizes LPS and increases the M2/M1 ratio in the scaffold-tissue interface will provide a sustainable pro-regenerative microenvironment more favorable to dental pulp tissue formation. Hence, our goal is to engineer a novel nanobody-laden photocrosslinkable hydrogel with fine-tuned stiffness and the ability to neutralize dentin LPS. This scaffold will enable controllable guidance of M1 macrophages activation, minimizing their presence within the root canal so that incoming monocytes can polarize into M2 cells, infiltrate the hydrogel, and secret an anti-inflammatory cytokine milieu to foster dental pulp tissue formation. We propose the following aims: (Aim 1) to determine the effect of scaffold's stiffness on M1/M2 macrophage polarization, (Aim 2) to neutralize dentin LPS and reduce M1 polarization, and (Aim 3) to evaluate the nanobody-laden scaffold's immunomodulatory capacity in vivo. Successful completion of these aims will generate data on the interplay between scaffold's properties and macrophage function, forming the basis for an R01 submission and the development of additional novel immunomodulatory materials.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Cristiane Miranda Franca其他文献

Cristiane Miranda Franca的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Cristiane Miranda Franca', 18)}}的其他基金

Engineering Immunomodulatory Scaffolds for Dental Pulp Regeneration
用于牙髓再生的免疫调节支架工程
  • 批准号:
    10371368
  • 财政年份:
    2022
  • 资助金额:
    $ 15.46万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 15.46万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 15.46万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 15.46万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.46万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 15.46万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 15.46万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 15.46万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 15.46万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 15.46万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 15.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了